Dr. Glenn van Langenhove - REDUCE Studie

Related Links

  • Dr. Glenn van Langenhove über die REDUCE Studie Wie nutzen Patienten CardioSecur ACTIVE? Dies wurde in REDUCE, der ersten explorativen Studie getestet.In diesem Video berichtet Kardiologe Dr. Glenn van Langenhove REDUCE und darüber, wie Patienten unser mobiles EKG verwenden.

Zurück

Neueste Artikel

[Translate to German:]

Meet us at the EPS 2025

Innovation grows through collaboration — looking forward to connecting at EPS!

On Friday we’ll be at the European Pacing Symposium (EPS), one of the most important gatherings for the Electrophysiology…

Company
Company

Meet us at the ICASM 2025

We’re looking forward to attending the 71st International Congress of Aviation and Space Medicine (ICASM) in Singapore, a key event for the Aviation healthcare community. 

Our team will be there to…

Company
Company

Meet us at the IATA WSOC

We’re excited to exhibit at IATA WSOC 2025 in Xiamen, China! 

As a key event in the aviation sector calendar, this conference brings together thought leaders, professionals, and innovators from across…

Company
Company

Meet us at the Heart Rhythm Congress 2025

We’re excited to showcase CardioSecur Vector-ECGi at Heart Rhythm Congress in Birmingham, on 6–7 October 2025.

Find us at Stand B20 to explore how this innovative solution supports advanced pacing…

Company
Company